This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Colorectal carcinoma is a type of cancer that develops in the colon or rectum, the final parts of the large intestine. It is the third most commonly diagnosed cancer in men and women in the United States and the second leading cause of cancer-related deaths. The exact cause of colorectal carcinoma is unknown, however, it is linked to a variety of factors, including age, genetics, lifestyle, and environmental factors. Age is the most significant risk factor for colorectal carcinoma. It is most commonly diagnosed in individuals over the age of 50. Individuals with a family history of the disease, such as a parent or sibling, are also at an increased risk. Additionally, those with inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis are at an increased risk. Poor lifestyle habits, such as a diet low in fiber, high in fat and red meat, and lack of physical activity, can also increase a person’s risk. Finally, exposure to certain environmental toxins such as asbestos and radiation has also been linked to an increased risk of colorectal carcinoma. Early detection is key for successful treatment of colorectal carcinoma. Screening tests can detect precancerous polyps in the colon or rectum, which can be surgically removed and prevent cancer from developing. Additionally, regular colonoscopies can detect colorectal carcinoma in its early stages, when treatment is most successful. Treatment options for colorectal carcinoma include chemotherapy, radiation, and surgery.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States